Author pages are created from data sourced from our academic publisher partnerships and public sources.
Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients.
- G. Lippi, G. Targher, M. Montagnana, G. Salvagno, G. Zoppini, G. Guidi
- Medicine, Biology
- Archives of pathology & laboratory medicine
- 20 October 2009
CONTEXT A strong independent association has been recently observed between elevated red blood cell distribution width (RDW) and increased incidence of cardiovascular events. OBJECTIVE To assess… Expand
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
Aims/hypothesisNon-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease in type 2 diabetes. Currently, there is a lack of information on associations… Expand
Prevalence of subclinical hypothyroidism in patients with chronic kidney disease.
- M. Chonchol, G. Lippi, G. Salvagno, G. Zoppini, M. Muggeo, G. Targher
- Clinical journal of the American Society of…
- 1 September 2008
BACKGROUND AND OBJECTIVES Subclinical primary hypothyroidism is highly prevalent in the general population, especially in the elderly. However, the prevalence of subclinical primary hypothyroidism in… Expand
Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
OBJECTIVE Recent studies have suggested an association between hyperuricemia and adverse renal outcomes in nondiabetic populations. Data on the relationship between hyperuricemia and the risk of… Expand
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.
- G. Targher, M. Chonchol, +6 authors M. Muggeo
- Journal of the American Society of Nephrology…
- 1 August 2008
It is unknown whether chronic kidney disease (CKD) is associated with nonalcoholic fatty liver disease among patients with type 2 diabetes. We followed 1760 outpatients with type 2 diabetes and… Expand
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
- R. de Marco, F. Locatelli, G. Zoppini, G. Verlato, E. Bonora, M. Muggeo
- Diabetes care
- 1 May 1999
OBJECTIVE This population-based study, carried out in the framework of the Verona Diabetes Study, investigated mortality from specific causes in known type 2 diabetic patients. RESEARCH DESIGN AND… Expand
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study
- M. Trombetta, G. Spiazzi, G. Zoppini, M. Muggeo
- Alimentary pharmacology & therapeutics
- 1 November 2005
Non‐alcoholic liver steatosis is associated with metabolic syndrome and type 2 diabetes. The prevalence of this condition in type 2 diabetes is estimated to be between 28 and 55%. Non‐alcoholic liver… Expand
Mortality from site-specific malignancies in type 2 diabetic patients from Verona.
OBJECTIVE The aim of the present work was to compare mortality from site-specific malignancies in type 2 diabetic patients with those in the general population. RESEARCH DESIGN AND METHODS… Expand
Metabolic Effects of Aerobic Training and Resistance Training in Type 2 Diabetic Subjects
OBJECTIVE To assess differences between the effects of aerobic and resistance training on HbA1c (primary outcome) and several metabolic risk factors in subjects with type 2 diabetes, and to identify… Expand
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
- G. Targher, C. Byrne, A. Lonardo, G. Zoppini, C. Barbui
- Journal of hepatology
- 1 September 2016
BACKGROUND & AIMS There have been many studies of the effects of non-alcoholic fatty liver disease (NAFLD) and the risk of cardiovascular disease (CVD), but these have produced conflicting results.… Expand